EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 2.578
March 31, 2026 -0.90
December 31, 2025 -1.038
September 30, 2025 -0.4795
June 30, 2025 -0.8384
March 31, 2025 1.140
December 31, 2024 -0.6255
September 30, 2024 -0.6824
June 30, 2024 -0.4896
March 31, 2024 -0.9679
December 31, 2023 -2.534
September 30, 2023 -1.183
June 30, 2023 -1.247
March 31, 2023 -1.537
December 31, 2022 -1.558
September 30, 2022 -1.244
June 30, 2022 -1.316
March 31, 2022 -1.196
December 31, 2021 -1.004
Date Value
September 30, 2021 -0.9386
June 30, 2021 -1.029
March 31, 2021 -0.8425
December 31, 2020 -0.9947
September 30, 2020 -0.7891
June 30, 2020 -0.6512
March 31, 2020 -0.5639
December 31, 2019 -0.5637
September 30, 2019 -0.5399
June 30, 2019 -0.546
March 31, 2019 -0.4598
December 31, 2018 -1.681
September 30, 2018 -3.877
June 30, 2018 -0.7055
March 31, 2018 -2.352
December 31, 2017 -0.2891
September 30, 2017 -0.1989
June 30, 2017 -0.2077
March 31, 2017 -0.1942

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
Fulcrum Therapeutics, Inc. -0.3433
Definium Therapeutics, Inc. -1.436
LeonaBio, Inc. -0.8011